Wednesday, June 12, 2024 11:54:02 PM
Absolutely NO INVESTMENT FIRM, INSIDER or credible lending institution takes Sint for anything other than the joke that it is; hence it is left alone.
Setting aside for a second that this post was meant in an antagonist manner (disinformation technique), as this is your goto statement, im beginning to wonder if this is done on purpose so you can claim it? Not you specifically but accounts like yours that use this statement to try to deflect from the development side of Sintx. You have little else other than the suppressed stockprice with the excessive dilution/reverse splits that comes with it, and lack of any ownership to really point to; exception being pre-IPO. This is only true until its not and theres a lot of reasons for this not to stay this way forever.
You seem to want people to believe that this means Sintx is a joke. However outside of the markets there is nothing to imply Sintx is a joke. Not the research showing that Silicon Nitride is destined for great things in the medical field. Not Zimmer Biomet involvement. Not Morgan Ceramics involvement. Nor any of its other strategic partners. Certainly not the US military which is working with Sintx on developing several products. Working with the US military should be your first clue that Sintx is not a joke as you seem to want people to believe. Before you bring up some rando company that you are aware that folded but worked with the military, make sure it was in a similar financial state. As in little if any real debt and a plethora of product candidates along with major strategic partners.
Having said all that you said SINT is a joke not Sintx.
This contract will address material challenges in propulsion and guidance technology for next generation high-temperature Department of the Air Force systems.
https://ir.sintx.com/news-events/press-releases/detail/231/sintx-technologies-receives-additional-sbir-contract-for-3d
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
https://ir.sintx.com/news-events/press-releases/detail/223/sintx-technologies-enters-into-a-second-long-term-supply
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
https://ir.sintx.com/news-events/press-releases/detail/220/sintx-subsidiary-technology-assessment-transfer-to
SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS
https://ir.sintx.com/news-events/press-releases/detail/217/sintx-technologies-enters-a-long-term-supply-agreement-for
SINTX TECHNOLOGIES AWARDED PHASE I CONTRACT FROM THE MISSILE DEFENSE AGENCY FOR ELECTROCHEMICAL MACHINING
https://ir.sintx.com/news-events/press-releases/detail/209/sintx-technologies-awarded-phase-i-contract-from-the
SINTX TECHNOLOGIES AWARDED MULTI-YEAR DARPA CONTRACT TO DEVELOP CMCs AND HIGH TEMPERATURE COATINGS FOR TURBINE ENGINES
https://ir.sintx.com/news-events/press-releases/detail/207/sintx-technologies-awarded-multi-year-darpa-contract-to
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS
https://ir.sintx.com/news-events/press-releases/detail/202/sintx-technologies-awarded-department-of-energy-grant-for
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
List of Markets Sintx can participate in and products in development:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174489883
========================================
Sintx valuation should be greater than $230m based on comparable company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174491281
========================================
Silicon Nitride = Next Gen Hip Implant Material
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
Cancer-Causing Effects of Orthopaedic Metal Implants in Total Hip Arthroplasty
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11011042/
Oral Cancer around Dental Implants: Are the Clinical Manifestations and the Oncogenic Mechanisms Unique?
https://www.intechopen.com/chapters/79298
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2026 12:30:10 PM
- SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution • GlobeNewswire Inc. • 03/23/2026 01:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 09:00:53 PM
- SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant • GlobeNewswire Inc. • 03/19/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
